← Back to all trials
Recruiting
NCT06393920
PulseSelect™ PFA Global Registry
Conditions: Atrial Fibrillation
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 1950
Sponsor: Medtronic Cardiac Ablation Solutions
Location: Jessa Ziekenhuis Hasselt
Summary
The PulseSelect™ PFA Global Registry is a prospective, global, multi-center, observational post-approval study. Subjects will be treated with the PulseSelect™ PFA System and followed according to SOC.
Eligibility Criteria
Inclusion Criteria:
* Subject is ≥ 18 years of age or minimum age as required by local regulations.
* Subject has been diagnosed with atrial fibrillation (AF)
* Planned procedure using commercially available PulseSelect™ PFA System.
* Willing to comply with study requirements and give informed consent (defined as legally effective, documented confirmation of a subject's voluntary agreement to participate in this clinical study) or authorization per institution and geographical requirements.
Exclusion Criteria:
* Subject is enrolled in a concurrent study that has not been approved for concurrent enrollment by the global study manager.
* Subject with exclusion criteria required by local law.
Source: ClinicalTrials.gov (NCT06393920). StuddyBuddy aggregates publicly available trial information.